Health & Medicine
-
Pharmaceutical Companies Race to Develop COVID-19 Antiviral Pill: Will it Work?
Seeing huge progress in vaccine technology and development, there's more hope in speeding up antiviral pipelines through development of working Covid-19 pills. In fact, Merck & Co., Inc., an American multinational pharmaceutical company, anticipates authorization for its oral COVID-19 antiviral drug, molnupiravir, by the end of the year, November as earliest.
Latest Research Articles
Experts Warn Pet Owners to be Vigilant of Hookworms, a Parasite Immune to All Treatments
-
Man Who Refused Treatment After Getting Bit by Bat Dies From Rabies, Illinois' First Case in 70 Years
-
Gene Editing Among Livestock May Increase Resistance to Diseases
Does Worsening Air Pollution Cause More Intense Thunderstorms? Experts Are Trying to Find Out
Social Inequality Heightened as Climate Change Worsens
-
Mild COVID-19 Conditions Could Affect the Brain and Body from Months After Infection
-
Bats Found in Laos Carry Virus Strikingly Similar to SARS-Cov-2
-
New COVID-19 Vaccine from China 79% Effective Against the Delta Variant
-
Future Generations Will Experience More Climate Disasters than Their Ancestors Ever Will
-
Millions of Guatemalans Face Starvation Due to Climate Change, Fueling Migration Crisis
-
Experts Raise Warning as Sudden Canine Deaths Linked to Toxic Blue-Green Algae
-
Delirium: Scary Long-Term Effect in Patients With Severe COVID-19 Emerges
MOST POPULAR
-
Top 10 of the World's Most Dangerous Invasive Species and the Devastating Impact on Ecosystems
-
3I/ATLAS Update: What Did ExoMars Trace Gas Orbiter Capture at Close Range Before Comet Disappeared Behind the Sun?
-
Hurricane Melissa Targets Southeast Bahamas and Bermuda After Historic Category 5 Jamaica Landfall
-
Microplastics Health Effects: Are Environmental Toxins and Plastic in the Bloodstream Dangerous?
-
7 Climate Change Animals Showing Incredible Species Adaptation and Thriving in a Warming World
